B-type natriuretic peptide (BNP) and its equimolarly secreted, more stable N-terminal cleavage product NT-proBNP are increasingly accepted as biomarkers for heart failure: High levels are used for diagnosis of heart failure in emergency units and decreasing levels may indicate treatment success in heart failure patients [1]. The gene discussed is NPPB; the disease is heart failure.